ISLD 2024

Dr. Dimitris Strakas (DDS, MSc, PhD) was born in 1975 in Volos Greece, where he has a private laser dental clinic since 2003.

He completed his studies in Aristotle University of Thessaloniki in 2002, and his Master of Science in Lasers in Dentistry, in RWTH Aachen University in 2006.

Since 2007 he is an adjunct faculty member and lecturer of the Aachen Dental Laser Center (AALZ) at RWTH Aachen University and from 2009 the Scientific Director of AALZ Greece. This is the Greek branch of Aachen Dental Laser Center, providing Certified Education to dentists, with Seminars, Workshops, Mastership Courses and MSc studies in the fields of Laser Dentistry and Laser Safety.

In 2013 founded the Laser Clinic Department at Aristotle University of Thessaloniki, which he is still in charge of.

In 2017 he received his PhD in Aristotle University of Thessaloniki, Department of Operative Dentistry.

Since 2017 he is a University Scholar at the Department of Operative Dentistry, in School of Dentistry, Aristotle University of Thessaloniki, Greece. Since 2019 he is a Visiting Professor at MIU University Cairo.

Since 2021 he is the Scientific Director of Aachen Dental Laser Center (AALZ).

He is the Secretary General of the International Society for Laser Dentistry (ISLD), Vice - President of the Hellenic Academy for Laser Dentistry (HALD), Member of the Deutschen Gesellschaft für Laserzahnheilkunde e.V. (DGL), Past Chairman of the World Federation of Laser Dentistry – European Division (WFLD-ED) and Past - President of the Greek Society for Laser Dentistry (GSLD).

He has many publications and articles on laser dentistry in Greek and international magazines. He has authored one book and translated in Greek three books for Laser Dentistry.

He is an Associate Editor for Lasers in Dental Science (LIDS), member of the Editorial Board of Laser Magazine (the International magazine of Laser Dentistry by Oemus Publications) and a reviewer for several peer-reviewed scientific Journals, including Lasers in Medical Science (LIMS), Photomedicine and Laser Surgery, International Journal of Paediatric Dentistry and others.

He has given a variety of lectures in Greek and International Congresses, meetings and workshops.

A nationally recognized leader in innovations in health care, Jonathan “Jack” Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations – the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana’s Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention’s Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine.

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including executive and governance roles at companies that have done that - Health Dialog, Humana, Therasense, Dexcom (DXCM), Stericycle, Mako Surgical, Velano Vascular, Digital Reasoning and Hubble Telemedical. Today he serves as a director and chairman of the board of Biolase (BIOL), and as a director for Par8o, and SmartSteward He also serves on advisory board roles for Blue Door Health and Avellino Labs. He has earned certificates in Governance and Audit from the Harvard Business School.

Keynote Speakers

Important Dates